Augmentin is a branded combination of amoxicillin and clavulanate, and this β‑lactamase‑inhibiting component is the primary reason its price is consistently higher than standard amoxicillin. Across U.S. and EU pharmacies, Augmentin typically shows wider cost variation due to manufacturer pricing, formulation complexity, and insurance reimbursement rules. These differences become especially noticeable when comparing Augmentin with amoxicillin directly through Augmentin vs Amoxicillin, where the clavulanate factor drives both clinical advantages and higher retail cost.
Pricing varies significantly by dosage — including 250mg, 500mg, 875mg, and extended‑release XR formulations — with higher strengths and XR tablets typically positioned at the upper end of the price spectrum. Form also plays a major role: tablets and capsules are generally more affordable, while pediatric oral suspension (Suspension) often carries a higher per‑mL cost due to packaging and stability requirements.
Insurance coverage can substantially reduce out‑of‑pocket expenses, especially for generics, though branded Augmentin may still involve higher copays depending on the plan. Retail pharmacies, discount pharmacies, and online providers show notable price differences, making pharmacy type an important factor in total cost. A full breakdown of these variables is available in the Pricing section.
Augmentin, a combination of amoxicillin and clavulanate, consistently carries a higher retail price compared with standard aminopenicillins. The inclusion of clavulanate — a β‑lactamase inhibitor that protects amoxicillin from enzymatic degradation — increases manufacturing complexity and positions Augmentin as a branded, clinically enhanced product. This pharmacological advantage is the primary driver behind its elevated cost relative to plain amoxicillin, a difference highlighted in the broader Augmentin clinical and therapeutic overview.
Pricing also varies depending on where the medication is purchased. Online pharmacies often provide lower baseline prices due to reduced overhead and competitive discount models, while traditional brick‑and‑mortar pharmacies may show higher retail ranges influenced by location, supply chain factors, and brand‑specific stocking policies. These discrepancies are especially noticeable for higher‑dose formulations and pediatric suspensions, where packaging and stability requirements further affect cost.
Insurance coverage plays a major role in determining final out‑of‑pocket expenses. Generic amoxicillin is typically placed in lower copay tiers, whereas branded Augmentin may fall into higher tiers depending on the plan’s formulary. Patients with comprehensive prescription benefits often see substantial reductions in cost, while those without insurance may encounter significant price variation across pharmacies. Understanding these insurance dynamics is essential for accurately estimating total treatment expense.
Augmentin pricing varies substantially across its core strengths — 250mg, 500mg, 875mg, and extended‑release XR. Higher strengths generally cost more due to increased amoxicillin content and the fixed amount of clavulanate, which raises production complexity. The number of tablets per prescription also directly affects total cost: larger 20–30‑tablet packs typically show better per‑tablet pricing, while small 10‑tablet packs often appear more expensive on a per‑dose basis. These dynamics make dosage selection and quantity important factors when estimating real‑world treatment expenses.
Lower strengths such as 250mg are commonly used for mild infections and pediatric adjustments, resulting in lower average pricing. Mid‑range 500mg tablets remain the most frequently dispensed strength in outpatient care, offering moderate pricing and broad clinical applicability. The 875mg strength is typically reserved for more severe infections and therefore sits at the higher end of the price spectrum. XR formulations, designed for sustained plasma exposure, consistently rank as the most expensive option due to specialized release mechanisms and limited generic availability.
| Strength | Typical Price Range | Notes |
|---|---|---|
| 250mg | $12–$25 | Mild infections |
| 500mg | $18–$35 | Moderate infections |
| 875mg | $25–$60 | Severe infections |
| XR | $40–$90 | Extended release |
Augmentin is available in several formulations — standard tablets, capsules, pediatric suspension, and extended‑release XR tablets — each with distinct pricing characteristics. Tablets remain the most common and typically offer the most stable pricing across pharmacies. Capsules are similar in cost, though availability varies by region. XR tablets consistently rank as the highest‑priced form due to specialized release technology and limited generic competition.
Suspension formulations often appear more expensive on a per‑mL basis. This is driven by several factors: clavulanate is less stable in liquid form, requiring more complex manufacturing and packaging; pediatric formulations must meet stricter flavoring, stability, and dosing accuracy standards; and pharmacies frequently stock multiple bottle sizes, creating variability in retail pricing. These production and distribution considerations make suspension one of the costlier forms despite its essential role in pediatric therapy.
| Form | Price Range | Notes |
|---|---|---|
| Tablets | $18–$60 | Most common |
| Capsules | $20–$55 | Similar to tablets |
| Suspension | $25–$70 | Pediatric use |
| XR | $40–$90 | High-strength |
The price gap between generic amoxicillin and branded Augmentin is one of the most significant cost differences within the aminopenicillin class. Generic amoxicillin is widely available, inexpensive to manufacture, and produced by multiple suppliers, which keeps its retail price low across pharmacies. In contrast, Augmentin contains clavulanate, a β‑lactamase inhibitor that enhances amoxicillin’s activity against resistant pathogens. This additional component increases production complexity and stability requirements, making Augmentin consistently more expensive than plain amoxicillin.
Brand‑name Augmentin also carries higher pricing due to proprietary formulation standards, stricter quality controls, and limited generic competition in certain markets. Even when generic amoxicillin/clavulanate combinations are available, they often remain more costly than standalone amoxicillin because clavulanate is more expensive to produce and less stable, especially in liquid formulations. These differences are clearly illustrated in comparative clinical and pricing discussions such as Augmentin vs Amoxicillin, where the clavulanate factor is the primary driver of elevated cost.
Overall, patients choosing between generic amoxicillin and Augmentin should expect a substantial price difference. While amoxicillin remains one of the most affordable oral antibiotics, Augmentin’s enhanced spectrum and branded formulation place it in a higher cost tier across retail, discount, and online pharmacies.
Augmentin and amoxicillin differ significantly in price due to formulation complexity and clinical positioning. Amoxicillin, available as a widely distributed generic, typically ranges from $8–$25 depending on dosage, pharmacy type, and insurance coverage. Its low manufacturing cost and broad generic availability make it one of the most economical first‑line antibiotics in outpatient care.
Augmentin, by contrast, ranges from $20–$60, reflecting the added clavulanate component that protects amoxicillin from β‑lactamase degradation. This enhancement improves clinical effectiveness against resistant pathogens but also increases production cost. As a result, Augmentin consistently appears in higher copay tiers and shows greater price variation across pharmacies. A detailed comparison is available in Augmentin vs Amoxicillin, where clinical and economic differences are outlined side‑by‑side.
| Drug | Typical Price | Notes |
|---|---|---|
| Amoxicillin | $8–$25 | Generic widely available |
| Augmentin | $20–$60 | Contains clavulanate |
These pricing differences make Augmentin a more costly option, though often clinically justified for infections involving β‑lactamase‑producing organisms.
Augmentin pricing varies widely depending on the type of pharmacy. Retail brick‑and‑mortar pharmacies typically show the highest baseline prices due to operational overhead, brand stocking policies, and regional market factors. These pharmacies often provide consistent availability across strengths and forms but may lack aggressive discounting options.
Online pharmacies frequently offer lower prices, driven by reduced overhead and competitive pricing models. Many online providers also feature subscription discounts, coupon integrations, and bulk‑order savings. However, online purchasing carries risks: counterfeit antibiotics, improper storage conditions, and unverified sellers can compromise medication quality. Patients should rely only on licensed, accredited online pharmacies when purchasing Augmentin or any β‑lactam antibiotic.
Discount pharmacies and warehouse‑style retailers often provide the most competitive pricing, especially for generics. Their large purchasing volumes and streamlined distribution models allow for lower per‑unit costs. These pharmacies can significantly reduce out‑of‑pocket expenses for both amoxicillin and Augmentin, making them an important option for uninsured patients. A broader breakdown of pricing variables is available in the Pricing section.
Insurance coverage plays a major role in determining how much patients ultimately pay for Augmentin. Because Augmentin is a branded combination of amoxicillin and clavulanate, it often falls into higher copay tiers compared with generic amoxicillin. Many insurance plans categorize Augmentin as a preferred brand or non‑preferred brand, which can lead to noticeably higher out‑of‑pocket costs, especially for patients with high‑deductible plans.
Generic amoxicillin is typically placed in the lowest copay tier due to its wide availability and low manufacturing cost. As a result, patients frequently pay only a minimal copay or even receive full coverage. In contrast, Augmentin’s enhanced formulation and clavulanate component increase production complexity, making it more expensive for insurers and patients alike. These differences are outlined in clinical and pricing discussions such as the broader Augmentin overview.
Insurance plans may also negotiate different rates with retail, discount, and online pharmacies, creating additional variability in final pricing. Patients without insurance often face the widest price range, while those with comprehensive prescription benefits may see substantial reductions in copay amounts. Understanding formulary placement and coverage rules is essential for accurately estimating total treatment cost.
Pediatric Augmentin pricing is primarily driven by suspension formulations, which are widely used for children due to flexible dosing and improved tolerability. Suspension products require more complex manufacturing because clavulanate is less stable in liquid form, increasing production and packaging costs. As a result, pediatric Augmentin often appears at the higher end of the price spectrum compared with tablet or capsule forms.
Dosage strength and bottle volume significantly influence final pricing. Smaller bottles may seem cheaper but often carry a higher per‑mL cost, while larger bottles provide better value but require careful dosing to avoid waste. Pediatric dosing guidelines, outlined in the Pediatric section, frequently involve weight‑based adjustments, which can affect how much suspension is needed for a full treatment course.
Additional factors such as flavoring, stability requirements, and pharmacy stocking policies also contribute to price variation. Retail pharmacies may charge more for pediatric suspensions due to handling and storage needs, while online pharmacies often provide competitive pricing but require careful verification to ensure product quality. Overall, pediatric Augmentin remains one of the more expensive formulations due to its specialized production and dosing flexibility.
Multiple external and market‑specific variables influence Augmentin pricing across regions. Geographic location plays a major role: U.S., EU, and international markets show different reimbursement rules, pharmacy markups, and distribution costs, creating noticeable price gaps for identical strengths and forms. Manufacturer differences also contribute to variability. Branded Augmentin typically carries higher pricing due to proprietary formulation standards, while generic amoxicillin/clavulanate products may be cheaper but still cost more than plain amoxicillin because clavulanate increases production complexity.
The dosage form further affects cost. Tablets and capsules generally show stable pricing, while pediatric suspensions and XR formulations often appear at the higher end due to specialized manufacturing and stability requirements. These combined factors — region, manufacturer, and formulation — are detailed in the broader Augmentin Pricing section, helping patients understand why identical prescriptions may vary significantly between pharmacies and locations.
Several strategies can help lower the total cost of Augmentin therapy. When clinically appropriate, switching to generic amoxicillin can significantly reduce expenses, as it is widely available and typically placed in the lowest copay tier. For infections that do not require clavulanate protection, this substitution offers substantial savings without compromising treatment effectiveness.
Discount pharmacies and warehouse‑style retailers often provide the most competitive pricing for both generics and combination antibiotics. Their large purchasing volumes and streamlined distribution models allow for lower per‑unit costs, making them an important option for uninsured patients. Insurance coverage also plays a major role: reviewing formulary tiers, preferred brands, and copay structures can help identify the most cost‑effective pharmacy options.
Patients can also compare retail, online, and discount pharmacy prices to find the best available rate. A broader overview of cost‑saving strategies and pricing variables is available in the Pricing section, which outlines practical steps for minimizing out‑of‑pocket expenses.